CNS Digital Therapeutics Market by Disease Indication (Alzheimers disease, Parkinsons disease and Epilepsy), End Users (Providers, Payers, Patients and Pharmaceutical Companies) - Analysis & Forecast 2019-2030
Report ID : 105 | Published Date : Jun 2019 | Pages : 210 | Region : Global | Report Code : HIT-8
CNS Digital Therapeutics Market Overviews and Introduction
Digital therapeutics is an emerging branch of medicine wherein the solutions to medical issues are provided through the use of technology. It can be defined as delivering therapeutic solutions to patients for prevention, management or for treatment of a disease or a medical disorder. It can be found in the form of smart phone or a computer tablet app, or some form of a cloud-based service connected to a wearable device.
The CNS digital therapeutic market is driven by increasing prevalence of neurological disorders, chronic diseases as well as continually rising geriatric population. Moreover, factors such as continuous monitoring of patients vital stats, ability to ensure adherence to medications, prompt reminders and the therapies being inexpensive drive the growth of this market. Furthermore the fact that it can be customized according the need of patient is a factor that plays role in driving the growth of this market. However, lack of awareness about digital therapeutics and risk of cyber threats acts a barrier for the growth of this market.
CNS Digital Therapeutics by Product
On the basis of product, CNS digital therapeutics market is segmented into Alzheimers disease, Parkinsons disease and epilepsy and other disease indications. Currently, other disease indications segment is holding the largest market share. Alzheimers disease segment is expected to grow at a higher CAGR in the forecast period owing to no definite cure being available for this disease in the market and digital therapeutics is expected to help in reducing the effects of the disease.
CNS Digital Therapeutics Market End Use
On the basis of end users the market can be segmented to providers, payers, patients and pharmaceutical companies. Patients is expected to be the dominating segment owing to the fact that these digital therapeutic solutions can be customized as per patients need and as companies are seen targeting patients directly rather than targeting payers and providers.
CNS Digital Therapeutics Market by Region
On the basis of region CNS digital therapeutic market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market followed by Europe and Asia Pacific. North America is dominating the CNS digital therapeutics market owing to increase in the incidences of chronic diseases, increased investment in CNS digital therapeutic devices through government funding. Moreover, early adoption of digital therapeutics in this region, is transforming the healthcare industry and is anticipated to lead the growth in this region in the forecast period. However, Asia Pacific is expected to witness the highest CAGR, owing to the factors such as rising population creating a vast target pool, rise in increasing incidences of chronic diseases, increasing usage of smartphones coupled with increasing funds by the government that help in improving the healthcare infrastructure.
CNS Digital Therapeutics Market Prominent Players
The prominent players in the CNS digital therapeutic market are Pear Therapeutics, Inc. Dthera Sciences, Akili Interactive Labs, Inc., Epicadence, CLICK THERAPEUTICS, INC., Cognoa, GAIA AG, MindSciences, Brainmarc, and MedRhythms, among others.